We are international
Donate
• about myeloma TEXT SIZE   
publications    back

Myeloma Minute
June 1, 2012
06.01.12
June 1, 2012
Share the Minute Facebook Tweet! Clinical Trials Donate to the IMF
 


Upcoming Events



World Experts Debate the Latest Advances in Myeloma Treatment

Wed, June 13, 2012

On June 13th, the IMWG Conference Series will kick off with a live webcast of a debate among world-recognized experts from the United States and Europe. You won’t want to miss this event, as four of our top myeloma researchers, Drs. Durie, Richardson, Palumbo and San Miguel, take on the first topic of the series: Making Sense of Treatment.

For the first time ever, the IMWG Conference will be webcast live and open to the public. Registration is free. This is one conference you won't want to miss! Register today.

Click HERE to register to attend the Conference in Amsterdam.
Click HERE to register for the live-streaming.


Register for Free Teleconference: Myeloma Updates 2012
Brian G.M. Durie, MD, summarizes highlights of ASCO/ EHA/ IMWG Summit for patients, family members, caregivers and healthcare professionals.
Thur, June 28, 2012
9/11 Coverage for Myeloma Pending: Will It Happen?

Patricia Workman, a volunteer at Ground Zero for two years, described her battle with both skin cancer (affecting her face) and multiple myeloma in the New York Times this week (“Logistics Hang Over a Ruling on 9/11 Cancer”). She is anxiously awaiting the ruling from the Sept. 11 Victim Compensation Fund to find out if she will be eligible for compensation. Myeloma is among the 14 categories of cancer being reviewed for eligibility. “The IMF has strongly supported the claims based upon the unexpected occurrence of myeloma in younger women exposed to toxic chemicals linked to the causation of myeloma,” says Dr. Brian Durie, co-founder and chairman of the IMF. “We await the announcement and stand ready to advocate for appropriate health coverage for all affected by this tragedy.” READ MORE


Could Targeting Cell Pathways Lead to Death of Myeloma Cells?
A recent study in the journal Nature suggests that may be the case. But Dr. Durie explains that while the findings referred to in this report are among many current efforts to interrupt the cellular pathways that can lead to cancer, they are still laboratory experiments. “It’s a long way—and a long time—from lab to patient.” In the meantime, he notes, “approved drugs, including something as simple as aspirin, may prove to have benefit. A recent report (ABC News, May 29) illustrates that regular use of aspirin can reduce the onset of skin cancer by about 15%. Hence, there is some greater enthusiasm about this type of research.” READ MORE

A Patient’s Blog: What Makes a Good Oncology Nurse?
Pat Killingsworth is convinced that while any type of nursing is difficult, oncology nurses handle some extreme challenges nearly every day. “It probably won’t surprise you to learn that the oncology nursing skill I value most is the ability to start an IV effortlessly, even in the most difficult-to-stick patients.” READ MORE
Attention Louisianans: Help Make an Oral Cancer Drug Parity Bill Law
Both legislative chambers in the state of Louisiana unanimously passed HB693, a bill providing parity for oral anti-cancer medications. The bill is now awaiting Governor Bobby Jindal’s signature. Please send him an email and urge him to sign the bill into law. READ MORE


Join Our Mailing List

12650 Riverside Drive, Suite 206 | North Hollywood, CA 91607-3421
Privacy Policy | Unsubscribe 
www.myeloma.org

 related articles